Jeremy Shao M.D.

Jeremy Shao MD, PhD serves as the Executive Director of Clinical Development at Prometheus Biosciences, Inc. since June 2022. Prior to this role, Jeremy Shao held positions at Gilead Sciences from August 2018 to June 2022, including Senior Director and Director of Clinical Research focused on Inflammation. Earlier experience includes serving as Clinical Research Physician at Amphastar Pharmaceuticals, Inc. from October 2017 to July 2018. Jeremy Shao's educational background encompasses a Doctor of Medicine (MD) from Emory University School of Medicine, a Doctor of Philosophy (PhD) in Experimental Medicine (Immunology) from McGill University, and a Bachelor of Science in Immunology also obtained from McGill University.